H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer

Neoplasma

Volumn 63, Issue 2, 2016, Pages 223-230

  Chen, J S ^a   Wang, Y F ^b   Zhang, X Q ^a   Lv, J M ^a   Li, Y ^a   Liu, X X ^b   Xu, T P ^c  

^a YiZheng People's Hospital   (China)

^b YANGZHOU UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Clinical relevance; Gastric cancer; H19; Invasion

Indexed keywords

BIOLOGICAL MARKER; RNA H19; UVOMORULIN; H19 LONG NON-CODING RNA; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE EXACERBATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RNA INTERFERENCE; STOMACH JUICE; STOMACH TUMOR; TUMOR CELL LINE;

BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GASTRIC JUICE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, LONG NONCODING; RNA, SMALL INTERFERING; ROC CURVE; STOMACH NEOPLASMS;

EID: 84969718883     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/207_150821N454     Document Type: Article

References (32)

1. MOORE MA, ATTASARA P, KHUHAPREMA T, LE TN, NGUYEN TH ET AL. Cancer epidemiology in mainland South-East Asia-past, present and future. Asian Pac J Cancer Prev 2010; 11 Suppl 2: 67-80.
2. JEMAL A, SIEGEL R, XU J, WARD E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300. http://dx.doi. org/10.3322/caac.20073
3. SAPARI NS, LOH M, VAITHILINGAM A, SOONG R. Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis. Plos One 2012; 7. http://dx.doi.org/10.1371/ iournal.pone.0036275
4. MILNE AN, CARNEIRO F, O'MORAIN C, OFFERHAUS GJA. Nature meets nurture: molecular genetics of gastric cancer. Human Genetics 2009; 126: 615-28. http://dx.doi. org/10.1007/s00439-009-0722-x
5. PONTING CP, BELGARD TG. Transcribed dark matter: meaning or myth? Human Molecular Genetics 2010; 19: R162-68. http://dx.doi.org/10.1093/hmg/ddq362
6. HAUPTMAN N, GLAVAC D. Long Non-Coding RNA in Cancer. International Journal ofMolecular Sciences 2013; 14: 4655-69. http://dx.doi.org/10.3390/ijms14034655
7. MUERS M. RNA Genome-wide views of long non-coding RNAs. Nature Reviews Genetics 2011; 12. http://dx.doi. org/10.1038/nrg3088
8. PONTING CP, OLIVER PL, REIK W. Evolution and Functions ofLong Noncoding RNAs. Cell 2009; 136: 629-41. http:// dx.doi.org/10.1016/j.cell.2009.02.006
9. QI P, DU X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Modern Pathology 2013; 26: 155-65. http://dx.doi.org/10.1038/ modpathol.2012.160
10. RINN JL, KERTESZ M, WANG JK, SQUAZZO SL, XU X, BRUGMANN SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs. Cell 2007; 129: 1311-23. http://dx.doi.org/10.1016/_i. cell.2007.05.022
11. CALIN GA, LIU CG, FERRACIN M, HYSLOP T, SPIZZO R, SEVIGNANI C, et al. Ultraconserved regions encoding ncRNAs are, altered in human leukemias and carcinomas. Cancer Cell 2007; 12: 215-29. http://dx.doi.org/10.1016/_i. ccr.2007.07.027
12. LIN R, MAEDA S, LIU C, KARIN M, EDGINGTON TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007; 26: 851-8. http://dx.doi.org/10.1038/si.onc.1209846
13. HIRATA H, HINODA Y, SHAHRYARI V, DENG GR, NAKAJIMA K, TABATABAI ZL, et al. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Research 2015; 75: 1322-31. http://dx.doi.org/10.1158/0008-5472. CAN-14-2931
14. OKUGAWA Y, TOIYAMA Y, HUR K, TODEN S, SAIGUSA S et al. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014; 35: 2731-9. http://dx.doi.org/10.1093/ carcin/bgu200
15. SUN M, JIN FY, XIA R, KONG R, LI JH ET AL. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. Bmc Cancer 2014; 14. http://dx.doi.org/10.1186/1471-2407-14-319
16. SUN M, XIA R, JIN FY, XU TP, LIU ZJ ET AL. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumor Biology 2014; 35: 1065-73. http://dx.doi.org/10.1007/ s13277-013-1142-z
17. GABORY A, JAMMES H, DANDOLO L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010; 32: 473-80. http://dx.doi.org/10.1002/ bies.200900170
18. THORVALDSEN JL, DURAN KL, BARTOLOMEI MS. Deletion of the H19 differentially methylated domain results in loss ofimprinted expression of H19 and Igf2. Genes Dev 1998; 12: 3693-702. http://dx.doi.org/10.1101/gad.12.23.3693
19. KONDO M, SUZUKI H, UEDA R, OSADA H, TAKAGI K et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 1995; 10: 1193-8.
20. BARSYTE-LOVEJOY D, LAU SK, BOUTROS PC, KHOSRAVI F, JURISICA I et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 2006; 66: 5330-7. http://dx.doi.org/10.1158/0008-5472.CAN-06-0037
21. ZHANG L, YANG F, YUAN JH, YUAN SX, ZHOU WP et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 2013; 34: 577-86. http://dx.doi. org/10.1093/carcin/bgs381
22. ZHUANG M, GAO W, XU J, WANG P, SHU Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014; 448: 315-22. http://dx.doi.org/10.1016/_i.bbrc.2013.12.126
23. YANG F, BI J, XUE X, ZHENG L, ZHI K et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012; 279: 3159-65. http://dx.doi. org/10.1111/j.1742-4658.2012.08694.x
24. ZHANG EB, HAN L, YIN DD, KONG R, DE W, CHEN J. c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol 2014; 31: 914. http://dx.doi.org/10.1007/ s12032-014-0914-7
25. BRANNAN CI, DEES EC, INGRAM RS, TILGHMAN SM. The product ofthe H19 gene may function as an RNA. Mol Cell Biol 1990; 10: 28-36. http://dx.doi.org/10.1128/MCB.10.1.28
26. LOTTIN S, VERCOUTTER-EDOUART AS, ADRIAENSSENS E, CZESZAK X, LEMOINE J et al. Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA. Oncogene 2002; 21: 1625-31. http://dx.doi.org/10.1038/si.onc.1205233
27. HIBI K, NAKAMURA H, HIRAI A, FUJIKAKE Y, KASAI Y, AKIYAMA S, et al. Loss of H19 imprinting in esophageal cancer. Cancer Res 1996; 56: 480-2.
28. LUO M, LI Z, WANG W, ZENG Y, LIU Z, QIU J. Long noncoding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013; 333: 213-21. http://dx.doi.org/10.1016/_i. canlet.2013.01.033
29. IMIG J, BRUNSCHWEIGER A, BRUMMER A, GUENNEWIG B, MITTAL N et al. miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction. Nat Chem Biol 2015; 11: 107-14. http://dx.doi.org/10.1038/ nchembio.1713
30. CUI L, ZHANG X, YE G, ZHENG T, SONG H, DENG H, et al. Gastric juice MicroRNAs as potential biomarkers for the screening ofgastric cancer. Cancer 2013; 119: 1618-26. http:// dx.doi.org/10.1002/cncr.27903
31. ZHOU X, YIN C, DANG Y, YE F, ZHANG G. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep 2015; 5: 115-16. http:// dx.doi.org/10.1038/srep11516
32. GAMALLO C, PALACIOS J, SUAREZ A, PIZARRO A, NAVARRO P et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. The American journal of pathology 1993; 142: 987-93.